GGrantIndex
Sort

25,944 grants matching neurodegeneration

Microglial heparan sulfate in the modulation of APOE function and neurodegeneration

$580,960
Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG

Microglial heparan sulfate in the modulation of APOE function and neurodegeneration

$580,960
Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AG

Microglial heparan sulfate in the modulation of APOE function and neurodegeneration

$580,960
Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG

Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain

$580,803
Jagdish Singh · North Dakota State University · R01 · FY2024 · AG

Ethanol and aldehyde dehydrogenases in health and disease

$580,667
Daria Mochly-Rosen · Stanford University · R01 · FY2022 · AA

Neurodegeneration in Aged SIV-Infected Primates

$580,627
Clayton A. Wiley · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · MH

Sleep-dependent modulation of cerebrospinal fluid flow in aging

$580,553
Laura Diane Lewis · Massachusetts Institute Of Technology · R01 · FY2025 · AG

Metabolic control of gut-brain axis in Familial Dysautonomia

$580,528
Frances Lefcort · Montana State University - Bozeman · R01 · FY2021 · DK

Metabolic control of gut-brain axis in Familial Dysautonomia

$580,528
Frances Lefcort · Montana State University - Bozeman · R01 · FY2019 · DK

Metabolic control of gut-brain axis in Familial Dysautonomia

$580,528
Valerie Copie · Montana State University - Bozeman · R01 · FY2022 · DK

Development and Maintenance of Lens Transparency

$580,527
John Irwin Clark · University Of Washington · R01 · FY2011 · EY

Development and Maintenance of Lens Transparency

$580,527
John Irwin Clark · University Of Washington · R01 · FY2012 · EY

Normobaric Oxygen Therapy for Spinal Cord Injury

$580,492
David D Fuller · University Of Florida · R01 · FY2025 · NS

Targeting FSH for the Therapy of Osteoporosis, Obesity and Neurodegeneration

$580,384
Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AG

Peripheral and Central Biomarkers of Alzheimer's Disease in Diverse Cohorts

$580,354
Minerva Maria Carrasquillo · Mayo Clinic Jacksonville · U19 · FY2023 · AG

Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias

$580,289
Judith Campisi · Buck Institute For Research On Aging · P01 · FY2022 · AG

Genetics, Biomarker and Bioinformatics Core

$579,748
Tatiana M. Foroud · Indiana University Indianapolis · P30 · FY2020 · AG

Project 1: Activation of Alternative L1 Lifecycles in the CNS with age and Alzheimer's Disease

$579,747
John M. Sedivy · Brown University · P01 · FY2022 · AG

Project 2: Role of Retrotransposable Element Activity in Drosophila Models of Alzheimer's Disease

$579,746
Stephen L. Helfand · Brown University · P01 · FY2022 · AG

Mitochondrial Complex III Free Radicals in Dementia-Related Proteinopathy and Neuroinflammation

$579,746
Anna Goldshmidt Orr · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AG

Understanding Amyloid Pathology - Multiomic Activity Imaging of Plaque Formation Dynamics (AmyMAP)

$579,740
Jeffrey Nicholas Savas · Northwestern University At Chicago · R01 · FY2022 · AG

Prevention of complement and immune-mediated Lewy body dementia

$579,735
Ole Isacson · Mclean Hospital · R01 · FY2019 · AG

N-Terminal Acetylation and Protein Degradation by the N-End Rule Pathway

$579,593
Alexander J Varshavsky · California Institute Of Technology · R01 · FY2016 · GM

Regulation of learning and memory by steroid hormone signaling during development and aging

$579,417
Kaveh Ashrafi · University Of California, San Francisco · R01 · FY2025 · AG

Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD

$579,380
Jonathan Kipnis · Washington University · R01 · FY2023 · AG